Citi analyst Daniel Grosslight maintained a Hold rating on 23andMe Holding (ME – Research Report) yesterday. The company’s shares closed yesterday at $1.52.
Grosslight covers the Healthcare sector, focusing on stocks such as Teladoc, 23andMe Holding, and Cardinal Health. According to TipRanks, Grosslight has an average return of 18.0% and a 40.00% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for 23andMe Holding with a $4.69 average price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $6.31 and a one-year low of $1.51. Currently, 23andMe Holding has an average volume of 2.53M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
VG Acquisition Corp is a blank check company.
Read More on ME:
- 23andMe to Report FY2024 First Quarter Financial Results
- 23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin
- 23andMe releases Simvastatin Medication Insight report
- 23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
- 23andMe Stock (NASDAQ:ME): Layoffs on the Horizon
